Adher Alsayed
Impact in
-
- Breast Cancer Treatment Studies
-
- Global Cancer Incidence and Screening
- Cancer Immunotherapy and Biomarkers
- Cancer Risks and Factors
- Cancer Cells and Metastasis
Papers in
- Oncology 16
- HER2/EGFR in Cancer Research 3
- Cancer Immunotherapy and Biomarkers 3
- Cancer Diagnosis and Treatment 3
- Cancer Risks and Factors 3
- Inflammatory Biomarkers in Disease Prognosis 2
- Viral-associated cancers and disorders 2
-
- Breast Cancer Treatment Studies 5
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Taher Al‐Tweigeri (11 shared papers)Dahish Ajarim (11 shared papers)Asma Tulbah (4 shared papers)Adnan Ezzat (2 shared papers)Naser Elkum (2 shared papers)Said Dermime (1 shared paper)Mohamed Alshabanah (1 shared paper)Ali S. Alzahrani (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Molecular and Cellular Biology (2 papers)Scientific Reports (1 paper)BMC Cancer (1 paper)Medical Oncology (1 paper)
- Partner nations
- Saudi ArabiaEgyptQatar
In The Last Decade
Adher Alsayed
17 papers receiving 300 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 111
- Oncology 173
- Internal Medicine 11
- Immunology 58
- Pathology and Forensic Medicine 35
Countries citing papers authored by Adher Alsayed
This map shows the geographic impact of Adher Alsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adher Alsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adher Alsayed more than expected).
Fields of papers citing papers by Adher Alsayed
This network shows the impact of papers produced by Adher Alsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adher Alsayed. The network helps show where Adher Alsayed may publish in the future.
Co-authors
The 25 scholars most cited alongside Adher Alsayed, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 88 | |
| 2 | 2018 | 44 | |
| 3 | 2009 | 38 | |
| 4 | 2020 | 23 | |
| 5 | 2022 | 23 | |
| 6 | 2021 | 18 | |
| 7 | 2014 | 15 | |
| 8 | 2015 | 14 | |
| 9 | 2017 | 13 | |
| 10 | 2000 | 10 | |
| 11 | 2022 | 7 | |
| 12 | 2020 | 4 | |
| 13 | 2013 | 3 | |
| 14 | 2020 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2021 | 0 |
About Adher Alsayed
Adher Alsayed is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery, having authored 19 papers that have together received 304 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer Diagnosis and Treatment (3 papers), Cancer Risks and Factors (3 papers), Cancer, Lipids, and Metabolism (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Cancer Research (111 citations), Oncology (173 citations), Internal Medicine (11 citations), Immunology (58 citations) and Pathology and Forensic Medicine (35 citations). Adher Alsayed has collaborated with scholars based in Saudi Arabia, Egypt and Qatar. Frequent co-authors include Taher Al‐Tweigeri, Dahish Ajarim, Asma Tulbah, Adnan Ezzat, Naser Elkum, Said Dermime, Mohamed Alshabanah, Ali S. Alzahrani, Huda H. Al‐Khalaf and Hazem Ghebeh. Their work appears in journals such as Journal of Clinical Oncology, Molecular and Cellular Biology, Scientific Reports, BMC Cancer and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.